Pierre Hofstee P, Bartho LA, McKeating DR, Radenkovic F, McEnroe G, Fisher JJ, Holland OJ, Vanderlelie JJ, Anthony V, Perkins AV, JSM C
Abstract Despite advances in immunotherapy, triple-negative breast cancer (TNBC) remains a major therapeutic challenge owing to its marked aggressiveness, low immunogenicity, and limited responsiveness to immune checkpoint blockade (ICB)
E., Eager, J., Maclaren, J
Selected: Standard Access Standard: this guide onlyAll-Access Lifetime: all 45 guides + downloadsEducational content only Educational use only not medical advice
SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells
Niacinamide: Brightens skin tone and improves skin texture